NOL9 is a 702 amino acid protein that resides within the nucleolus. The gene encoding NOL9 maps to human chromosome 1, which spans about 260 million base pairs and making up 8% of the human genome.
There are about 3,000 genes on chromosome 1, and considering the great number of genes there are also a large number of diseases associated with chromosome 1. Notably, the rare aging disease Hutchinson-Gilford progeria is associated with the LMNA gene which encodes lamin A. When defective, the LMNA gene product can build up in the nucleus and cause characteristic nuclear blebs. The mechanism of rapidly enhanced aging is unclear and is a topic of continuing exploration.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Nucleolar Protein 9 (NOL9) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Nucleolar Protein 9 (NOL9) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Nucleolar Protein 9 (NOL9) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Nucleolar Protein 9 (NOL9) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Nucleolar Protein 9 (NOL9) | ELISA Kit Customized Service Offer |
Organism species: Mus musculus (Mouse)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Nucleolar Protein 9 (NOL9) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Nucleolar Protein 9 (NOL9) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Nucleolar Protein 9 (NOL9) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Nucleolar Protein 9 (NOL9) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Nucleolar Protein 9 (NOL9) | ELISA Kit Customized Service Offer |
Organism species: Rattus norvegicus (Rat)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Nucleolar Protein 9 (NOL9) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Nucleolar Protein 9 (NOL9) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Nucleolar Protein 9 (NOL9) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Nucleolar Protein 9 (NOL9) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Nucleolar Protein 9 (NOL9) | ELISA Kit Customized Service Offer |
- "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
- "The DNA sequence and biological annotation of human chromosome 1." Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
- "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
- "Functional proteomic analysis of human nucleolus."Mol. Biol. Cell 13:4100-4109(2002) [PubMed] [Europe PMC] [Abstract]
- "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
- "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
- "Nol9 is a novel polynucleotide 5'-kinase involved in ribosomal RNA processing."EMBO J. 29:4161-4171(2010) [PubMed] [Europe PMC] [Abstract]
- "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
- "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
- "Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features."Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012) [PubMed] [Europe PMC] [Abstract]